Leadership Overview
Avara Pharmaceutical Services has 4 executives leading key functions including operations, financial strategy, human capital management, and corporate leadership.
Focused on delivering high-quality manufacturing solutions, Avara Pharmaceutical Services maintains a commitment to excellence in aseptic liquid filling, sterile injectables, and oral solid dose production for global pharmaceutical partners.
Focused on delivering high-quality manufacturing solutions, Avara Pharmaceutical Services maintains a commitment to excellence in aseptic liquid filling, sterile injectables, and oral solid dose production for global pharmaceutical partners.
Leadership Roles at Avara Pharmaceutical Services
Ca.Kunal Aust - Group Chief Financial Officer, Finance Lead For Automotive & Pharma
Ca.Kunal Aust, the Group Chief Financial Officer, Finance Lead For Automotive & Pharma at Avara Pharmaceutical Services, manages the fiscal health and capital allocation strategies. Overseeing financial reporting and budgetary planning, the Group Chief Financial Officer, Finance Lead For Automotive & Pharma ensures the organization maintains a robust balance sheet to support manufacturing expansion. This leadership role involves analyzing market trends within the pharmaceutical and automotive sectors to guide long-term investment decisions. By implementing stringent financial controls, Ca.Kunal Aust mitigates risk and enhances profitability across all business units. The Group Chief Financial Officer, Finance Lead For Automotive & Pharma collaborates with the executive team to secure funding for new sterile pharmaceutical technologies. Through precise financial modeling and resource management, the Group Chief Financial Officer, Finance Lead For Automotive & Pharma drives sustainable growth and ensures the company remains competitive in the demanding global manufacturing landscape.
Larry Lee - Chief Operating Officer
Larry Lee, the Chief Operating Officer at Avara Pharmaceutical Services, directs all manufacturing operations and supply chain logistics. Overseeing the production of aseptic liquid filling and sterile injectables, the Chief Operating Officer ensures strict adherence to quality standards across all facilities. This leadership role involves optimizing oral solid dose manufacturing workflows to increase throughput and efficiency. By managing complex production schedules, Larry Lee directly impacts the ability of the organization to meet client demand for pharmaceutical packaging solutions. The Chief Operating Officer coordinates with the broader leadership team to align operational capacity with market requirements. Through rigorous oversight of technical processes, the Chief Operating Officer maintains the integrity of the manufacturing environment. This focus on operational excellence supports the overall growth trajectory of the company while ensuring consistent delivery of high-quality pharmaceutical products to diverse global markets.
Robert Rothmann - President
Robert Rothmann, the President at Avara Pharmaceutical Services, architects the overarching corporate strategy and drives the long-term vision for the organization. Overseeing the integration of aseptic liquid filling and oral solid dose capabilities, the President ensures the company remains a leader in the pharmaceutical manufacturing sector. This leadership role involves cultivating strategic partnerships with global pharmaceutical firms to expand market reach. By setting clear performance objectives, Robert Rothmann guides the executive team toward achieving sustainable revenue growth and operational excellence. The President monitors industry shifts to adapt service offerings, ensuring the company provides cutting-edge packaging solutions. Through decisive leadership and a focus on quality, the President maintains the reputation of the organization as a reliable partner for sterile pharmaceutical production. This commitment to strategic growth positions the company to capitalize on emerging opportunities within the global healthcare supply chain.
Richard Mark - Chief Human Resources Officer
Richard Mark, the Chief Human Resources Officer at Avara Pharmaceutical Services, directs talent acquisition, organizational development, and employee engagement initiatives. Overseeing the recruitment of specialized technical staff for sterile manufacturing, the Chief Human Resources Officer ensures the workforce possesses the expertise required for complex pharmaceutical production. This leadership role involves designing performance management systems that align individual contributions with the core mission of the company. By fostering a culture of safety and innovation, Richard Mark improves retention and operational productivity. The Chief Human Resources Officer collaborates with other executives to implement training programs that address the evolving needs of the pharmaceutical industry. Through strategic workforce planning, the Chief Human Resources Officer supports the scaling of operations across regional markets. This focus on human capital ensures the organization maintains a high-performing team capable of delivering superior packaging and manufacturing solutions to clients.
Explore Leadership Teams in Manufacturing
Founded in 1781, Takeda Pharmaceutical Company engages in the research, development, manufacturing, and marketing of pharmaceutical products, over-the-counter medicines and quasi-drug consumer products, and other healthcare products. It offers pharmaceutical products in the areas of gastroenterology; oncology; neuroscience; and rare diseases, such as rare metabolic and hematology, and heredity angioedema, as well as plasma-derived therapies and vaccines. The company is headquartered in Tokyo, Japan
Company Leadership KS
AP
AM
SS
Zoetis discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers vaccines, medicated feed additives that offer medicines to livestock; and other pharmaceutical products, which comprise allergy and dermatology, pain and sedation, antiemetic, reproductive, and oncology products. It markets to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company is headquartered in Parsippany, New Jersey.
Company Leadership LP
RV
SA
MT
Santen Pharmaceutical Co., Ltd., is a Japanese pharmaceutical company, specializing in ophthalmology. With its ophthalmic products Santen holds the top share within the Japanese market and is one of the leading ophthalmic companies worldwide, with its products being sold in over 50 countries. The company was founded in 1890 by Kenkichi Taguchi, as Taguchi Santendo, and in 1925, Santendo Co., Ltd. was established.
Company Leadership TI
RN
FA
Soft gelatin capsule products, liquid preparations, medicinal plasters, ointments, and creams are produced at the Gunung Putri Plant. In producing these products, Gunung Putri Plant implements an Integrated Management System and has obtained ISO 9001:2015, ISO 14001:2015, ISO 45001:2018 and ISO 22000:2018 certificates. Meanwhile, sterile injection products and solid preparations in the form of tablets and capsules are produced at the Citeureup Plant. The Citeureup Plant also implements an Integrated Management System and has obtained ISO 9001:2015, ISO 14001:2015, ISO 45001:2018, and SNI ISO/IEC 17025:2017 certificates. In running the Toll Manufacturing business, Darya-Varia collaborates with an affiliated company, PT Medifarma Laboratories, at the Cimanggis Depok Plant. The Company has been trusted by local business partners and both for the domestic and international markets for the Export & Toll Manufacturing business and conducts technology transfer, lab and pilot trials, stability studies, procurement of raw materials and packaging, and commercial production of high-quality finished goods. Darya-Varia always ensures the quality and safety of each product, so that all of its products are certified halal. All plant facilities owned by Darya-Varia have implemented the halal guarantee system. Blue Sphere Singapore Pte Ltd (BSSPL) owns 92.13% stake in Darya-Varia. For 45 years, Darya-Varia has continued to progress in providing high quality health facilities. Through the mission of "building a healthier Indonesia for everyone one person at a time", Darya-Varia is always committed to providing a variety of quality products with the right strategy for the health of the Indonesian people. DARYA VARIA
Company Leadership CH
Frequently Asked Questions Regarding Avara Pharmaceutical Services Top Executives and Leadership Team
